2026-09-09 IR Notice Regarding Special Loss (non-consolidated) due to Impairment of Investment in an Equity-Method Affiliate 2026-09-09 IR Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ended July 2026 2026-06-10 IR Supplementary Materials of FY26 Q3 Consolidated Financial Results 2026-06-10 IR [Summary] Consolidated Financial Results for the Nine Months Ended April 30, 2026 (Under Japanese GAAP) 2026-04-30 R&D PharmaGABA® New Scientific Study Published in Leading International Journal - Accelerating Global Expansion and Adoption in the Food & Beverage Category - 2026-04-22 Media Pharma Foods Certified as 2026 Health & Productivity Management Outstanding Organization ― Fourth consecutive year of recognition; Group-wide commitment to "KENKO Investment" ― 2026-04-06 R&D Pharma Foods Co., Ltd. Acquires Exclusive Rights to Advance First-in-Class Adrenomedullin Program for CADASIL Across Key Asian Markets 2026-03-23 IR Supplementary Materials of Consolidated Financial Results for the Six Months Ended January 31, 2026 2026-03-13 IR Notice Regarding Revision of Full-Year Financial Results Forecast for the Fiscal Year Ending July 2026 2026-03-13 IR [Summary]Consolidated Financial Results for the Six Months Ended January 31, 2026 (Based on Japanese GAAP) More